| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/26/2009 | US20090082549 Sequence encoding amino acids 301-437 of the Fc region of the mouse immunoglobulin e molecule is genetically fused to pseudomonas exotoxin |
| 03/26/2009 | US20090082444 Compositions for the Treatment of Blood Disorders |
| 03/26/2009 | US20090082309 Inhibiting dipeptidylpeptidase proteolysis of glucagon-like peptide 1 by conjointly administering to the animal metformin and an inhibitor of dipeptidylpeptidase IV; treating Type II diabetes but not sufficient to suppress the immune system of the animal |
| 03/26/2009 | US20090082296 Mycobacterial antigens expressed during latency |
| 03/26/2009 | US20090082294 Diagnosis, prevention and treatment of cancer |
| 03/26/2009 | US20090082293 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 03/26/2009 | US20090082292 inhibiting angiogenesis; corneal graft rejection; age related macular degeneration; diabetic retinopathy; dermatological disease |
| 03/26/2009 | US20090082289 Adenoviral vectors having a protein IX deletion |
| 03/26/2009 | US20090082283 Dipeptides for Prevention of Muscle Breakdown and Microbial Infection |
| 03/26/2009 | US20090082282 Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| 03/26/2009 | US20090082281 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 03/26/2009 | US20090082280 peptidomimetics; sextapeptides; for stimulating elastogenesis and capillary dilatation |
| 03/26/2009 | US20090082279 Treating a condition associated with breakdown of the blood brain barrier by administering a peptide antagonist of zonulin that binds to the zonula occludens receptor, especially in the brain, yet does not physiologically modulate the opening of mammalian tight junctions |
| 03/26/2009 | US20090082278 Use of compounds inducing the synthesis of sirt proteins in or for the preparation of a cosmetic or pharmaceutical composition |
| 03/26/2009 | US20090082277 Potentiation of anticancer agents |
| 03/26/2009 | US20090082276 Selective vpac2 receptor peptide agonists |
| 03/26/2009 | US20090082275 Ob protein compositions and methods |
| 03/26/2009 | US20090082274 Collections of repeat proteins comprising repeat modules |
| 03/26/2009 | US20090082273 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 03/26/2009 | US20090082272 pharmacokinetics; sustained release; cost efficiency; industrial scale |
| 03/26/2009 | US20090082271 Agents that reduce apoe-induced impairment of mitochondria and methods of use thereof |
| 03/26/2009 | US20090082270 myostatin antagonist protein is substantially serum stable for a period of at least 24 hours; treating individuals with muscle wasting conditions and provides further insight into the regulation of myostatin gene expression; muscular disorders |
| 03/26/2009 | US20090082269 Agent for ameliorating heavy metal-induced disorders, and medicinal composition, food and cosmetic containing the same |
| 03/26/2009 | US20090082268 Muteins of Placental Growth Factor Type I, Preparation Method And Application Thereof |
| 03/26/2009 | US20090082267 Prevention and Reduction of Blood Loss |
| 03/26/2009 | US20090082266 Conjugate of water-soluble hyaluronic acid modification product with glp-a analogue |
| 03/26/2009 | US20090082265 Compositions and methods for treating diseases |
| 03/26/2009 | US20090082264 123 Human Secreted Proteins |
| 03/26/2009 | US20090082263 Drug and method for improving brain function |
| 03/26/2009 | US20090082262 Processed human chemokines PHC-1 and PHC-2 |
| 03/26/2009 | US20090082261 Urea-containing peptides as inhibitors of viral replication |
| 03/26/2009 | US20090082260 Combination of an immunosuppressant and a ppar gamma agonist for the treatment of an undesirable immune response |
| 03/26/2009 | US20090082259 Deuterium-enriched octreotide |
| 03/26/2009 | US20090082258 Means and Methods for Treating Advanced Stage Neuroblastoma |
| 03/26/2009 | US20090082257 MalPEG-Hb conjugate- containing compositions for delivering carbon monoxide (CO) to cells |
| 03/26/2009 | US20090082256 Concomitant pharmaceutical agents and use thereof |
| 03/26/2009 | US20090082255 by addition of surfactants providing a high long-term stability due to stress; storage stability to hydrophobic aggregation nuclei for several months under temperature stress; for the treatment of diabetes; FDA Orange book listed patent for insulin glargine recombinant |
| 03/26/2009 | US20090082254 Coupling of Polypeptides at the C-Terminus |
| 03/26/2009 | US20090082251 Mitochondrial DNA variants associated with metabolic syndrome |
| 03/26/2009 | US20090082250 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide |
| 03/26/2009 | US20090082249 Nutritional supplement for a category of hiv patients |
| 03/26/2009 | US20090081791 Intracellular delivery of small molecules, proteins, and nucleic acids |
| 03/26/2009 | US20090081790 Polynucleotide for Target Gene |
| 03/26/2009 | US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 03/26/2009 | US20090081730 Activatable recombinant neurotoxins |
| 03/26/2009 | US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR |
| 03/26/2009 | US20090081707 Human trk receptors and neurotrophic factor inhibitors |
| 03/26/2009 | US20090081705 Novel peptides and compositions which modulate apoptosis |
| 03/26/2009 | US20090081660 Compositions and methods for the diagnosis and treatment of tumor |
| 03/26/2009 | US20090081653 A nucleic acid regulating the expression of a gene responsive to insulin where the nucleic acid hybridizes under moderate stringency conditions to a hybridization probe; obesity; insulin-resistance syndrome; antidiabetic and -proliferative |
| 03/26/2009 | US20090081635 Modified heparinase iii and methods of sequencing therewith |
| 03/26/2009 | US20090081300 Agent for use in the case of fructose intolerance |
| 03/26/2009 | US20090081299 Sustained release of apo a-i mimetic peptides and methods of treatment |
| 03/26/2009 | US20090081298 Sustained release of apo a-i mimetic peptides and methods of treatment |
| 03/26/2009 | US20090081293 Sustained release of apo a-i mimetic peptides and methods of treatment |
| 03/26/2009 | US20090081285 Use of radical-capturing substances in a topical preparation for antipyretic treatment |
| 03/26/2009 | US20090081283 Tumor therapy with non-viral-based high affinitiy laminin receptor-targeted vectors |
| 03/26/2009 | US20090081280 Compositions and methods for modulating hemostasis |
| 03/26/2009 | US20090081276 Bioresorbable implant composition |
| 03/26/2009 | US20090081274 Mast cell-derived renin |
| 03/26/2009 | US20090081273 Medical Devices and Methods Including Polymers Having Biologically Active Agents Therein |
| 03/26/2009 | US20090081254 Hiv vaccine for mucosal delivery |
| 03/26/2009 | US20090081246 Method for isolating hepatitis c virus peptides |
| 03/26/2009 | US20090081241 comprising all of the heavy chain variable CDR regions of SEQ ID NOS:1, 2 and 3 and/or all of the light chain variable CDR regions of SEQ ID NOS:4, 5 and 6, specific for at least one human tumor necrosis factor alpha (TNF) protein |
| 03/26/2009 | US20090081232 Methods of treating diseases with anti-vegf antibodies |
| 03/26/2009 | US20090081231 Methods and compositions for use in treatment of patients with autoantibody positive disease |
| 03/26/2009 | US20090081229 Anti-pro87299 antibodies |
| 03/26/2009 | US20090081228 Cyr61 compositions and methods |
| 03/26/2009 | US20090081227 Promotong differentiation of neural stem cells to nerve cells for use in treating injury to central nerve system caused by brain infarction, hemorrhage and/or spinal cord injury |
| 03/26/2009 | US20090081226 Soluble HLA-E Molecules And Their Use For Diagnosing And Treating Pathologies |
| 03/26/2009 | US20090081225 PIF peptides biologic activities, site of action, and the antibody to detect PIF |
| 03/26/2009 | US20090081224 Compositions of polypeptides specific to pathogenic strains and their use as vaccines and in immunotheraphy |
| 03/26/2009 | US20090081222 Novel splice variants of the egf receptor |
| 03/26/2009 | US20090081217 Modified Chimeric Polypeptides with Improved Pharmacokinetic Properties |
| 03/26/2009 | US20090081215 Genetic products differentially expressed in tumors and use thereof |
| 03/26/2009 | US20090081214 Genetic products differentially expressed in tumors and use thereof |
| 03/26/2009 | US20090081209 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins |
| 03/26/2009 | US20090081206 Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals |
| 03/26/2009 | US20090081199 Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 03/26/2009 | US20090081198 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 03/26/2009 | US20090081194 Compositions and methods for reducing risk of development, or severity, of inappropriate immune response in eyes |
| 03/26/2009 | US20090081193 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 03/26/2009 | US20090081192 Methods of screening for compounds having anti-inflammatory activity |
| 03/26/2009 | US20090081191 Immunoglobulins; epithelial cell adhesion molecule (EpCAM) |
| 03/26/2009 | US20090081189 Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells |
| 03/26/2009 | US20090081188 Complex of factorix and polyoxyethylene glycol; stimulant blood coagulation; blood disorders |
| 03/26/2009 | US20090081187 Pharmacological vitreolysis |
| 03/26/2009 | US20090081186 Methods and compositions for preventing and/or treating pancreatitis |
| 03/26/2009 | US20090081185 Apoptotic agents |
| 03/26/2009 | US20090081184 Non-pancreatic proteases for controlling plasma cholecystokinin (cck) concentration and for treating pain |
| 03/26/2009 | US20090081183 HIV Transcription Repressor Complex and Compositions and Methods Based Thereon |
| 03/26/2009 | US20090081182 Modified Lecithin-Cholesterol Acyltransferase Enzymes |
| 03/26/2009 | US20090081181 Isolation of growth and differentiating factors from colostrum |
| 03/26/2009 | US20090081180 Antimicrobial polymer conjugates |
| 03/26/2009 | US20090081178 Phenolic Binding Peptides |
| 03/26/2009 | US20090081170 Cardiac progenitor cells |
| 03/26/2009 | US20090081168 Method of forming a peptide-receptor complex with zsig33 |
| 03/26/2009 | US20090081165 Bicyclic heteroaryl derivatives |
| 03/26/2009 | US20090081164 Use of a cyclosporin for the treatment of hepatitis C infection and pharmaceutical composition comprising said cyclosporin |
| 03/26/2009 | US20090081163 Cladribine regimen for treating multiple sclerosis |